Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors

scientific article published on 6 February 2007

Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1093/MUTAGE/GEL068
P698PubMed publication ID17284773
P5875ResearchGate publication ID6519546

P2093author name stringZdenko Herceg
P433issue2
P921main subjectepigeneticsQ26939
P304page(s)91-103
P577publication date2007-02-06
P1433published inMutagenesisQ15724554
P1476titleEpigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors
P478volume22

Reverse relations

cites work (P2860)
Q34487211A cross-sectional study of global DNA methylation and risk of colorectal adenoma
Q34113164A refined, rapid and reproducible high resolution melt (HRM)-based method suitable for quantification of global LINE-1 repetitive element methylation
Q91484672A review on arsenic carcinogenesis: Epidemiology, metabolism, genotoxicity and epigenetic changes
Q37949394An overview of cancer chemopreventive potential and safety of proanthocyanidins
Q35999967Analysis of Nucleosides in Municipal Wastewater by Large-Volume Liquid Chromatography Tandem Mass Spectrometry
Q28829867Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years
Q33886934Association between lifestyle factors and CpG island methylation in a cancer-free population.
Q53721508Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
Q51761835At the Crossroads Between Neurodegeneration and Cancer: A Review of Overlapping Biology and Its Implications.
Q34473441Biochemical mutagens affect the preservation of fungi and biodiversity estimations
Q97536301Can Vitamins, as Epigenetic Modifiers, Enhance Immunity in COVID-19 Patients with Non-communicable Disease?
Q34279875Cancer chemoprevention by dietary polyphenols: promising role for epigenetics
Q36591701Characterising the epigenome as a key component of the fetal exposome in evaluating in utero exposures and childhood cancer risk.
Q47612846Colder environments are associated with a greater cancer incidence in the female population of the United States
Q33862644Comparison of the DNA methylation profiles of human peripheral blood cells and transformed B-lymphocytes
Q23919015Considerations for using genetic and epigenetic information in occupational health risk assessment and standard setting
Q36149220Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer
Q35911261DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract
Q35966485DNA methylation dynamics in plants and mammals: overview of regulation and dysregulation.
Q37873228DNA methylation in cancer development, diagnosis and therapy--multiple opportunities for genotoxic agents to act as methylome disruptors or remediators.
Q34195371DNA methylation in endometrial cancer
Q35159029DNA methylation in white blood cells: association with risk factors in epidemiologic studies
Q38038406Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application
Q38018255Diet, nutrients, phytochemicals, and cancer metastasis suppressor genes
Q28384266Diet, the gut microbiome, and epigenetics
Q26858886Dietary epigenetics in cancer and aging
Q28472388Differential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell model
Q28395938Effects of arsenic exposure on DNA methylation and epigenetic gene regulation
Q42911316Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders
Q28385295Environmental toxicants, epigenetics, and cancer
Q38161341Epigenetic Alteration by DNA Promoter Hypermethylation of Genes Related to Transforming Growth Factor-β (TGF-β) Signaling in Cancer
Q35697918Epigenetic Contributions to the Relationship between Cancer and Dietary Intake of Nutrients, Bioactive Food Components, and Environmental Toxicants
Q38876530Epigenetic Mechanisms as an Interface Between the Environment and Genome
Q37345879Epigenetic alterations due to diet and Helicobacter pylori infection in gastric carcinogenesis.
Q27022002Epigenetic diet: impact on the epigenome and cancer
Q52595933Epigenetic information in chromatin and cancer.
Q34457187Epigenetic linkage of aging, cancer and nutrition
Q35573935Epigenetic mechanisms of pulmonary hypertension.
Q37077821Epigenetic programming of the germ line: effects of endocrine disruptors on the development of transgenerational disease
Q53184356Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
Q34508252Epigenetic targets of bioactive dietary components for cancer prevention and therapy
Q34705578Epigenetic transgenerational actions of vinclozolin on the development of disease and cancer
Q34085532Epigenetics and cancer
Q34687601Epigenomic biomonitors: global DNA hypomethylation as a biodosimeter of life-long environmental exposures.
Q35711392Epigenomics of ovarian cancer and its chemoprevention
Q64098410Evaluation of DNA Methylation Changes and Micronuclei in Workers Exposed to a Construction Environment
Q38808103Future of environmental research in the age of epigenomics and exposomics
Q39760740Future research perspectives on environment and health: the requirement for a more expansive concept of translational cancer research
Q38414652Gene-specific promoter methylation is associated with micronuclei frequency in urothelial cells from individuals exposed to organic solvents and paints
Q40038281Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells
Q35878556Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds
Q36002022Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure.
Q38110262Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis
Q37680071Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma
Q28577672Histone acetylation and steroid receptor coactivator expression during clofibrate-induced rat hepatocarcinogenesis
Q34363873Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells
Q33407811Identification of histone modifications in biomedical text for supporting epigenomic research
Q51187064Impact of Phytochemicals and Dietary Patterns on Epigenome and Cancer.
Q33731768Insight into the impact of diabetes mellitus on the increased risk of hepatocellular carcinoma: mini-review
Q28080281Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention
Q57918250Insulin-like growth factor 2hypomethylation of blood leukocyte DNA is associated with gastric cancer risk
Q36243658Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects
Q92003943Key actors in cancer therapy: epigenetic modifiers
Q64124594LncRNA-MALAT1 as a novel biomarker of cadmium toxicity regulates cell proliferation and apoptosis
Q47393672Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma
Q47663995Lowly methylated region analysis identifies EBF1 as a potential epigenetic modifier in breast cancer.
Q27015643Maternal nutritional status, C(1) metabolism and offspring DNA methylation: a review of current evidence in human subjects
Q38107445Measuring the exposome: a powerful basis for evaluating environmental exposures and cancer risk
Q93168401Mechanisms of DNA-reactive and epigenetic chemical carcinogens: applications to carcinogenicity testing and risk assessment
Q37665565Methylation and expression of PTPN22 in esophageal squamous cell carcinoma
Q35870726Methylation status of COX-2 in blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population.
Q35053159Methylome analysis and epigenetic changes associated with menarcheal age
Q33661037MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospects
Q34025838Molecular targets of epigenetic regulation and effectors of environmental influences
Q41990459New Insights into the Epigenetics of Hepatocellular Carcinoma.
Q28084085Nuclear and mitochondrial DNA alterations in newborns with prenatal exposure to cigarette smoke
Q34457478Nutrients, foods, and colorectal cancer prevention
Q26750817Nutrition, aging and cancer: lessons from dietary intervention studies
Q37706886Oxidative stress-induced epigenetic changes associated with malignant transformation of human kidney epithelial cells
Q42702889Persistent organic pollutants and promoter hypermethylation of the O(6)-methylguanine-DNA methyltransferase gene
Q35637318Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective
Q90318694Promoter Hypomethylation Is Responsible for Upregulated Expression of HAI-1 in Hepatocellular Carcinoma
Q35792273Prospects for epigenetic epidemiology
Q57293808Proteomic analysis of the OGT interactome: novel links to epithelial-mesenchymal transition and metastasis of cervical cancer
Q37036306Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors
Q33548990Quantitative detection of DNA methylation states in minute amounts of DNA from body fluids
Q35989817RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients
Q38062515RUNX family: Regulation and diversification of roles through interacting proteins
Q36877220RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking.
Q36213023Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II α
Q37370439Reactivation of RASSF1A in breast cancer cells by curcumin
Q90122154Relationship between DLEC1 and PBX3 promoter methylation and the risk and prognosis of gastric cancer in peripheral blood leukocytes
Q36401944Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry
Q37206472Second-hand smoke and human lung cancer
Q37301148Superoxide dismutase 1 knockdown induces oxidative stress and DNA methylation loss in the prostate.
Q64120695Supplementing Genistein for Breeder Hens Alters the Fatty Acid Metabolism and Growth Performance of Offsprings by Epigenetic Modification
Q64964982The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
Q23914496The association between global DNA methylation and telomere length in a longitudinal study of boilermakers
Q36990438The epigenome as a potential mediator of cancer and disease prevention in prenatal development
Q38241688The potential role of O-GlcNAc modification in cancer epigenetics.
Q39846650The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers
Q35159486The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma
Q37151661Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation
Q38776904Ubiquitin Protein Ligase Ring2 Is Involved in S-phase Checkpoint and DNA Damage in Cells Exposed to Benzo[a]pyrene
Q34463056Unexplored potentials of epigenetic mechanisms of plants and animals-theoretical considerations
Q28249524Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen

Search more.